QIAGEN NV (QGEN)
41.04
-0.20
(-0.48%)
USD |
NYSE |
Apr 20, 16:00
41.26
+0.22
(+0.55%)
Pre-Market: 07:01
QIAGEN Price : 41.04 for April 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 1.66 |
| CDT Equity, Inc. | 3.355 |
| LENZ Therapeutics, Inc. | 10.13 |
| Liminatus Pharma, Inc. | 0.2151 |
| Oruka Therapeutics, Inc. | 68.87 |
Price Related Metrics
| PE Ratio | 20.08 |
| PS Ratio | 4.083 |
| PEG Ratio | 0.0479 |
| Price to Book Value | 2.238 |
| Price to Free Cash Flow | 19.08 |
| Earnings Yield | 4.98% |
| Market Cap | 8.454B |
| PEGY Ratio | 0.0469 |
| Operating PE Ratio | 16.36 |
| Normalized PE Ratio | 18.44 |